Intranasal Ketamine: What Patients Should Know

· Updated November 2026 · Aazaz Haq, MD

Ketamine

When people say "ketamine nasal spray," they can mean two very different things. One is Spravato, an FDA-approved medicine given in a certified clinic. The other is a compounded ketamine spray made by a pharmacy, sometimes prescribed for use at home. I get asked about both, so here is how I think about them.

The short answer

Spravato is the FDA-approved esketamine nasal spray, given in certified clinics with monitoring and usually covered by insurance. Compounded ketamine nasal sprays are not FDA-approved for depression, deliver less predictable doses, and are sometimes used at home without supervision. I recommend ketamine treatment in a supervised medical setting.

Spravato: the approved nasal spray

Spravato contains esketamine, one of ketamine's two mirror-image forms. It is FDA-approved for adults with treatment-resistant depression and for depression with suicidal thoughts. Every dose is taken in a certified clinic, followed by at least two hours of monitoring. Doses are fixed at 56 or 84 mg, and the device delivers a measured amount each time.

Because it went through the full FDA process, Spravato is covered by most insurance plans, usually after prior authorization. You can read more in How Does Esketamine Work?

Compounded ketamine nasal spray

Compounded sprays contain regular ketamine, the 50/50 mix of both forms. They are not FDA-approved for depression. Research on them is limited: a small randomized study in 2014 found a rapid antidepressant effect from a single intranasal dose, but larger trials have not followed.

The bigger issue for me is dosing and supervision. Absorption through the nose varies with technique and congestion, and a home spray bottle does not measure doses the way a medical device does. The FDA has warned that compounded ketamine used outside a medical setting carries added risk because nobody is present to monitor breathing, blood pressure or confusion. Ketamine can also be misused.

I am very conservative about at-home ketamine. In my view, ketamine treatment is safest in a supervised medical setting, and that is how we practice.

What a supervised session looks like

  • We check your blood pressure before the dose. If it is too high, we do not treat that day.
  • You give yourself the spray under a clinician's direction.
  • A staff member monitors you for at least two hours. Dissociation, sleepiness and nausea are common and usually fade during that time.
  • You go home with a driver and do not drive until the next day after a full night's sleep.

Other options if a nasal spray is not right

We also offer ketamine by IV infusion or intramuscular injection, which are self-pay, and TMS, which is covered by most plans. Our side-by-side comparison shows how they differ.

If you are trying to sort out which route makes sense for you, request a consultation call. Our patient advocate will help you decide whether a psychiatric evaluation is the right next step.

Questions I hear often

Why does Spravato cost more than compounded ketamine?

Spravato is a brand-name medicine that went through years of large clinical trials, and it is delivered by a device that measures each dose. The list price is high, but because it is FDA-approved, insurance usually covers most of it. Compounded ketamine is cheaper to buy but is rarely covered and lacks the same testing and safety program.

Is the experience different from IV ketamine?

In my experience, most people find Spravato gentler than IV or intramuscular ketamine. The effects build over several minutes as each spray is absorbed, and they usually fade well before the two-hour monitoring period ends.

What if I am already using ketamine at home?

Tell us. We will not judge you, and knowing what you have taken helps us plan safely. Some people switch to supervised treatment; others prefer to continue with their current prescriber. Either way, honest information leads to safer care.

Who may be a candidate for Spravato

Spravato is approved for adults with major depression who have not done well on at least two antidepressants, and for adults with depression and active suicidal thoughts. Before starting, we review your diagnosis, prior treatments, blood pressure, medical history and any history of substance use. Spravato is not used during pregnancy, and people with certain blood vessel conditions should not take it. The evaluation is also when we talk about schedule, transportation and cost, because a treatment that cannot be completed does not help anyone.

References

  1. Lapidus KA, et al. A randomized controlled trial of intranasal ketamine in major depressive disorder. Biol Psychiatry. 2014. PubMed
  2. Popova V, et al. Esketamine nasal spray in treatment-resistant depression (TRANSFORM-2). Am J Psychiatry. 2019. PubMed
  3. Janssen Pharmaceuticals. SPRAVATO (esketamine) nasal spray prescribing information. Source

Ready to take the next step?

Nothing here commits you to treatment. Start with a free consultation call with our patient advocate, who calls you back within one business day.

Or call us(571) 378-13986849 Old Dominion Drive, Suite 315, McLean
Call (571) 378-1398Request a consultation call